Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations

Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations

Podrobná bibliografie
Hlavní autoři:	Pellagatti, A, Steeples, V, Sharma, E, Repapi, E, Yip, B, Armstrong, R, Dolatshad, H, Lockstone, H, Taylor, S, Giagounidis, A, Vyas, P, Papaemmanuil, E, Woll, P, Killick, S, Malcovati, L, Hellstrom-Lindberg, E, Cazzola, M, Smith, C, Boultwood, J
Médium:	Conference item
Vydáno:	Elsevier 2017

Podobné jednotky

The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes.
Autor: Yip, B, a další
Vydáno: (2017)

The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
Autor: Boultwood, J, a další
Vydáno: (2014)

Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations
Autor: Pellagatti, A, a další
Vydáno: (2018)

Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches
Autor: Armstrong, R, a další
Vydáno: (2017)

COMPREHENSIVE ANALYSIS OF MUTATION STATUS, GENE EXPRESSION PROFILES, BLOOD AND BONE MARROW COUNTS AND OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Autor: Pellagatti, A, a další
Vydáno: (2014)

Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1 mutant myelodysplastic syndromes
Autor: Dolatshad, H, a další
Vydáno: (2016)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
Autor: Pellagatti, A, a další
Vydáno: (2010)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.
Autor: Pellagatti, A, a další
Vydáno: (2011)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome
Autor: Pellagatti, A, a další
Vydáno: (2011)

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
Autor: Pellagatti, A, a další
Vydáno: (2009)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
Autor: Pellagatti, A, a další
Vydáno: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
Autor: Pellagatti, A, a další
Vydáno: (2010)

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
Autor: Pellagatti, A, a další
Vydáno: (2010)

Gene Expression Profiling of CD34(+) Cells in Patients with Myelodysplastic Syndromes
Autor: Pellagatti, A, a další
Vydáno: (2008)

Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.
Autor: Pellagatti, A, a další
Vydáno: (2016)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia
Autor: Boultwood, J, a další
Vydáno: (2009)

Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes.
Autor: Pellagatti, A, a další
Vydáno: (2009)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes: differences between early and advanced cases and analysis of apoptosis-related genes
Autor: Pellagatti, A, a další
Vydáno: (2007)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q)
Autor: Pellagatti, A, a další
Vydáno: (2005)

Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes.
Autor: Pellagatti, A, a další
Vydáno: (2013)

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
Autor: Boultwood, J, a další
Vydáno: (2010)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes: Involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
Autor: Pellagatti, A, a další
Vydáno: (2006)

Genome-wide analysis of copy number change and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density SNP arrays
Autor: Wang, L, a další
Vydáno: (2007)

Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia
Autor: Yusuke Shiozawa, a další
Vydáno: (2018-09-01)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes (British Journal of Haematology (2008) 142, (57-64))
Autor: Pellagatti, A, a další
Vydáno: (2009)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes.
Autor: Pellagatti, A, a další
Vydáno: (2008)

Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.
Autor: Boultwood, J, a další
Vydáno: (2007)

Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
Autor: Pellagatti, A, a další
Vydáno: (2006)

High Throughput Targeted Gene Sequencing in 738 Myelodysplastic Syndromes Patients Reveals Novel Oncogenic Genes, Rare Driver Mutations and Complex Molecular Signatures with Potential Impact for Patient Diagnosis and Prognosis in the Clinic
Autor: Papaemmanuil, E, a další
Vydáno: (2012)

Somatic Mutation of SF3B1, a Gene Encoding a Core Component of RNA Splicing Machinery, in Myelodysplasia with Ring Sideroblasts
Autor: Malcovati, L, a další
Vydáno: (2011)

Myelodysplastic/myeloproliferative disorders
Autor: Luca Malcovati, a další
Vydáno: (2008-01-01)

Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia
Autor: Pellagatti, A, a další
Vydáno: (2014)

Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia.
Autor: Pellagatti, A, a další
Vydáno: (2014)

Regulation of RNA Splicing: Aberrant Splicing Regulation and Therapeutic Targets in Cancer
Autor: Koji Kitamura, a další
Vydáno: (2021-04-01)

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
Autor: Malcovati, L, a další
Vydáno: (2011)

Discovering transcription and splicing networks in myelodysplastic syndromes.
Autor: Hongyan Wang, a další
Vydáno: (2013-01-01)

Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality.
Autor: Dimitriou, M, a další
Vydáno: (2016)

L-leucine increases translation of RPS14 and LARP1 in erythroblasts from del(5q) myelodysplastic syndrome patients
Autor: Bello, E, a další
Vydáno: (2018)

The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts
Autor: Boultwood, J, a další
Vydáno: (2008)

Aberrant splicing and drug resistance in AML
Autor: Rosalia de Necochea-Campion, a další
Vydáno: (2016-09-01)